Abstract
Cancer is one of the most dreaded diseases worldwide and the incidence is on the rise in both developing and developed countries. It is treated by chemotherapy, radiotherapy and surgery. In spite of advances in treatment strategies, cancer still remains a major cause of death. Research is on for development of better drugs which are more effective and simultaneously cause fewer side effects. Plants have been used for the treatment of various ailments of man and animals since ages. They are being screened extensively to explore the possibility of development of economically viable anticancer drugs. Natural products of plant origin currently constitute a considerable proportion of commercially available antineoplastic drugs. This review gives an insight into commercially available anticancer drugs of plant origin and also patents granted to plant derived components, extracts and polyherbal formulations possessing anticancer activity. The exhaustive work reviewed here on antineoplastic activity of various plants both in vitro and experimental models throughout the world will help design further research in this field.
Keywords: Anticancer, antineoplastic, cancer, extracts, herbs, in vitro, medicinal plants, neoplasm, malignant, progenitor cell, oncogene, tumor suppressor gene, metastatic tumors, chronic inflammation, carcinogenic food additives and pollutants
Recent Patents on Biotechnology
Title: Antineoplastic Potential of Medicinal Plants
Volume: 5 Issue: 2
Author(s): M. Shynu, K. P. Gupta and M. Saini
Affiliation:
Keywords: Anticancer, antineoplastic, cancer, extracts, herbs, in vitro, medicinal plants, neoplasm, malignant, progenitor cell, oncogene, tumor suppressor gene, metastatic tumors, chronic inflammation, carcinogenic food additives and pollutants
Abstract: Cancer is one of the most dreaded diseases worldwide and the incidence is on the rise in both developing and developed countries. It is treated by chemotherapy, radiotherapy and surgery. In spite of advances in treatment strategies, cancer still remains a major cause of death. Research is on for development of better drugs which are more effective and simultaneously cause fewer side effects. Plants have been used for the treatment of various ailments of man and animals since ages. They are being screened extensively to explore the possibility of development of economically viable anticancer drugs. Natural products of plant origin currently constitute a considerable proportion of commercially available antineoplastic drugs. This review gives an insight into commercially available anticancer drugs of plant origin and also patents granted to plant derived components, extracts and polyherbal formulations possessing anticancer activity. The exhaustive work reviewed here on antineoplastic activity of various plants both in vitro and experimental models throughout the world will help design further research in this field.
Export Options
About this article
Cite this article as:
Shynu M., P. Gupta K. and Saini M., Antineoplastic Potential of Medicinal Plants, Recent Patents on Biotechnology 2011; 5 (2) . https://dx.doi.org/10.2174/187220811796365662
DOI https://dx.doi.org/10.2174/187220811796365662 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
Call for Papers in Thematic Issues
Advances in Metagenomics: Innovations and Patentable Biotechnologies
Metagenomics has revolutionized biotechnology by enabling the comprehensive analysis of microbial communities in diverse environments. The application of metagenomic approaches has led to the discovery of novel genes, enzymes, bioactive compounds, and metabolic pathways with significant industrial, environmental, and medical applications. This Thematic Issue will focus on recent advancements in ...read more
AI-Driven Innovations in Medical Biotechnology: Transforming Healthcare with Machine Learning and Deep Learning Technologies
The integration of Artificial Intelligence (AI) and Machine Learning (ML) into medical biotechnology is significantly advancing healthcare technologies. These innovations are improving diagnostics, disease prevention, treatment personalization, and medical research. By harnessing vast datasets, AI and ML algorithms are enabling healthcare professionals to make more accurate predictions, optimize patient outcomes, ...read more
Related Journals

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Response to Hypericin-Induced Photodamage
Current Medicinal Chemistry Meet Our Editorial Board Member:
Current Pharmaceutical Design The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Bio Distribution
Current Drug Metabolism Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)
Current Drug Targets Disruption of the Keap1-Containing Ubiquitination Complex as an Antioxidant Therapy
Current Topics in Medicinal Chemistry Development of Metal-Based Drugs and Application in Clinical Treatment
The Natural Products Journal Combined Transarterial Chemoembolization with Microwave Ablation <i>versus</i> Microwave Alone for Treatment of Medium Sized Hepatocellular Carcinoma
Current Cancer Drug Targets Statins and Cancer
Anti-Cancer Agents in Medicinal Chemistry Kv7 Channels as Targets for the Treatment of Pain
Current Pharmaceutical Design Pharmacokinetic Profiles of Anticancer Herbal Medicines in Humans and the Clinical Implications
Current Medicinal Chemistry Extracellular Vesicles in Tumor Diagnosis: A Mini-Review
Current Molecular Medicine Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression
MicroRNA Telomerase Modulation in Therapeutic Approach
Current Pharmaceutical Design Polyphenols in Food: Cancer Prevention and Apoptosis Induction
Current Medicinal Chemistry Anticancer Drugs Targeting the Apoptotic Pathway
Medicinal Chemistry Reviews - Online (Discontinued) Diselenides and Selenocyanates as Versatile Precursors for the Synthesis of Pharmaceutically Relevant Compounds
Current Organic Synthesis A Review of Clinical Trials of Cancer and Its Treatment as a Vaccine
Reviews on Recent Clinical Trials Combining Gene Therapy and Radiation Against Cancer
Current Gene Therapy Sp/KLF Family and Tumor Angiogenesis in Pancreatic Cancer
Current Pharmaceutical Design <sup>1</sup>H NMR-Linked Urinary Metabolic Profiling of Niemann-Pick Class C1 (NPC1) Disease: Identification of Potential New Biomarkers using Correlated Component Regression (CCR) and Genetic Algorithm (GA) Analysis Strategies
Current Metabolomics